ICD-10 Coding for Ependymoma(C71.5, C71.5B, C71.5M)
Comprehensive guide on ICD-10 coding for ependymoma, including malignant and benign classifications, documentation requirements, and coding pitfalls.
Complete code families applicable to Ependymoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C71.5 | Malignant neoplasm of cerebral ventricle | Use for confirmed malignant ependymomas located in the cerebral ventricle. |
|
| C72.0 | Malignant neoplasm of spinal cord | Use for confirmed malignant ependymomas located in the spinal cord. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutEpendymoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Ependymoma.
Omitting molecular findings in documentation.
Impact
Clinical: Inaccurate treatment planning., Regulatory: Non-compliance with coding updates., Financial: Potential reimbursement issues.
Mitigation
Include molecular testing results in reports., Cross-check with histological findings.
Using benign codes for malignant ependymomas.
Impact
Reimbursement: Incorrect reimbursement rates., Compliance: Non-compliance with coding standards., Data Quality: Inaccurate clinical data.
Mitigation
Verify histological findings before assigning codes.
Histology and molecular findings
Impact
Failure to document molecular findings can lead to audit issues.
Mitigation
Ensure all histological and molecular data are included in reports.